<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Electromyographic and histopathological studies were performed on 112 skeletal muscles in 101 subjects with <z:hpo ids='HP_0003198'>myopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnostic significance of large action potentials (LAPs) in <z:hpo ids='HP_0003198'>myopathy</z:hpo> was studied </plain></SENT>
<SENT sid="2" pm="."><plain>LAPs were defined as those action potentials with a duration of over 13 ms and an amplitude of over 3 mV (peak to peak) </plain></SENT>
<SENT sid="3" pm="."><plain>The following results were obtained: Most muscles with LAPs showed the grouped <z:mpath ids='MPATH_127'>atrophy</z:mpath> of small fibers of neuropathic change in addition to myopathic findings </plain></SENT>
<SENT sid="4" pm="."><plain>Even in <z:hpo ids='HP_0003198'>myopathy</z:hpo> most LAPs reflected neuropathic change, except in thyrotoxic <z:hpo ids='HP_0003198'>myopathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>LAPs were not related to an increase of connective tissue increasing the impedance in volume conduction of the action potentials </plain></SENT>
<SENT sid="6" pm="."><plain>LAPs were frequently seen in: progressive <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> of limb-girdle type; scapuloperoneal <z:mpath ids='MPATH_554'>dystrophy</z:mpath>; distal <z:hpo ids='HP_0003198'>myopathy</z:hpo>; oculopharyngeal <z:mpath ids='MPATH_554'>dystrophy</z:mpath>; myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath>; <z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e>; and thyrotoxic <z:hpo ids='HP_0003198'>myopathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Other types of <z:hpo ids='HP_0003198'>myopathy</z:hpo> had few LAPs </plain></SENT>
<SENT sid="8" pm="."><plain>There were two types of progressive <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>One had LAPs frequently and the other, rarely </plain></SENT>
<SENT sid="10" pm="."><plain>In myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> the muscles with LAPs showed scattered small angular fibers, possibly indicating neurogenic changes </plain></SENT>
<SENT sid="11" pm="."><plain>Interstitial <z:hpo ids='HP_0100614'>myositis</z:hpo> had LAPs more frequently than parenchymatous <z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>The <z:hpo ids='HP_0011010'>chronic</z:hpo> phase of <z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e> had LAPs more frequently than the <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011011'>subacute</z:hpo> phases </plain></SENT>
<SENT sid="13" pm="."><plain>In thyrotoxic <z:hpo ids='HP_0003198'>myopathy</z:hpo> the muscles with LAPs rarely showed definite neuropathic change histopathologically </plain></SENT>
<SENT sid="14" pm="."><plain>Therefore, LAPs in thyrotoxic <z:hpo ids='HP_0003198'>myopathy</z:hpo> may not indicate denervation </plain></SENT>
</text></document>